SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-106844
Filing Date
2022-04-15
Accepted
2022-04-15 16:31:03
Documents
15
Period of Report
2022-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d328041d8k.htm   iXBRL 8-K 27619
2 EX-10.1 d328041dex101.htm EX-10.1 7537
3 EX-10.2 d328041dex102.htm EX-10.2 7503
7 GRAPHIC g328041g0415194222388.jpg GRAPHIC 2965
  Complete submission text file 0001193125-22-106844.txt   180082

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA freq-20220411.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20220411_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20220411_pre.xml EX-101.PRE 11709
9 EXTRACTED XBRL INSTANCE DOCUMENT d328041d8k_htm.xml XML 3472
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 22830324
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences